Nomura Micro Science Co., Ltd. (TYO:6254)
Japan · Delayed Price · Currency is JPY 4,590.00
-135.00 (-2.86%)
May 29, 2026, 3:30 PM JST
Nomura Micro Science Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 56,245 | 96,359 | 73,021 | 49,595 | 31,901 | |
Revenue Growth (YoY) | -41.63% | 31.96% | 47.23% | 55.46% | 5.07% |
Cost of Revenue | 43,539 | 75,249 | 57,614 | 39,223 | 24,245 |
Gross Profit | 12,706 | 21,110 | 15,407 | 10,372 | 7,656 |
Selling, General & Admin | 6,039 | 5,357 | 4,384 | 3,558 | 3,017 |
Research & Development | - | 381 | 341 | 256 | 207 |
Operating Expenses | 6,039 | 5,738 | 4,759 | 3,822 | 3,223 |
Operating Income | 6,667 | 15,372 | 10,648 | 6,550 | 4,433 |
Interest Expense | -2,323 | -1,899 | -589 | -57 | -31 |
Interest & Investment Income | 147 | 72 | 100 | 45 | 34 |
Currency Exchange Gain (Loss) | 1,058 | -260 | 651 | -186 | 106 |
Other Non Operating Income (Expenses) | 79 | 114 | 9 | 62 | 39 |
EBT Excluding Unusual Items | 5,628 | 13,399 | 10,819 | 6,414 | 4,581 |
Gain (Loss) on Sale of Investments | 17 | - | - | 1,036 | - |
Gain (Loss) on Sale of Assets | - | - | 11 | - | - |
Asset Writedown | - | - | -5 | -1 | - |
Other Unusual Items | - | - | 2 | - | -4 |
Pretax Income | 5,645 | 13,399 | 10,827 | 7,449 | 4,577 |
Income Tax Expense | 1,827 | 3,200 | 2,849 | 1,643 | 1,286 |
Net Income | 3,818 | 10,199 | 7,978 | 5,806 | 3,291 |
Net Income to Common | 3,818 | 10,199 | 7,978 | 5,806 | 3,291 |
Net Income Growth | -62.57% | 27.84% | 37.41% | 76.42% | 25.71% |
Shares Outstanding (Basic) | 38 | 38 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 39 | 39 | 38 | 37 | 37 |
Shares Change (YoY) | 0.28% | 1.69% | 1.91% | 0.45% | 0.43% |
EPS (Basic) | 100.35 | 270.75 | 213.48 | 156.88 | 89.39 |
EPS (Diluted) | 98.42 | 263.64 | 209.70 | 155.53 | 88.55 |
EPS Growth | -62.67% | 25.72% | 34.83% | 75.64% | 25.15% |
Free Cash Flow | 3,301 | -22,305 | -19,005 | 3,664 | 955 |
Free Cash Flow Per Share | 85.09 | -576.57 | -499.55 | 98.15 | 25.70 |
Dividend Per Share | - | 80.000 | 62.500 | 37.500 | 21.250 |
Dividend Growth | - | 28.00% | 66.67% | 76.47% | 54.55% |
Gross Margin | 22.59% | 21.91% | 21.10% | 20.91% | 24.00% |
Operating Margin | 11.85% | 15.95% | 14.58% | 13.21% | 13.90% |
Profit Margin | 6.79% | 10.58% | 10.93% | 11.71% | 10.32% |
Free Cash Flow Margin | 5.87% | -23.15% | -26.03% | 7.39% | 2.99% |
EBITDA | 8,359 | 17,025 | 10,955 | 6,741 | 4,605 |
EBITDA Margin | 14.86% | 17.67% | 15.00% | 13.59% | 14.44% |
D&A For EBITDA | 1,692 | 1,653 | 307 | 191 | 172 |
EBIT | 6,667 | 15,372 | 10,648 | 6,550 | 4,433 |
EBIT Margin | 11.85% | 15.95% | 14.58% | 13.21% | 13.90% |
Effective Tax Rate | 32.37% | 23.88% | 26.31% | 22.06% | 28.10% |